Inventiva (IVA) Gains from Investment Securities (2021 - 2024)
Inventiva (IVA) recorded quarterly Gains from Investment Securities of $5.6 million in Q4 2024, up 160.88% quarter-over-quarter from -$9.2 million in Q2 2024, and up 52.23% on a YoY basis from $3.7 million in Q1 2024.
Inventiva (IVA) Gains from Investment Securities (2021 - 2024) Analysis & Trends
Inventiva's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $5.6 million for Q4 2024.
- In Q4 2024, Gains from Investment Securities rose 52.23% year-over-year to $5.6 million; the TTM figure through Dec 2024 stood at $5.6 million (up 52.23% YoY), while the FY2025 annual figure was $209.3 million, up 158.9% from the prior year.
- Gains from Investment Securities was $5.6 million for Q4 2024 at Inventiva, up from -$9.2 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $5.6 million in Q4 2024 to a low of -$9.2 million in Q2 2024.
- Historically, Gains from Investment Securities has averaged $443547.5 across 3 years, with a median of $2.2 million in 2021.
- Biggest YoY gain for Gains from Investment Securities was 52.23% in 2024; the steepest drop was 611.06% in 2024.
- A 3-year view of Gains from Investment Securities shows it stood at -$1.9 million in 2021, then jumped by 293.64% to $3.7 million in 2023, then soared by 52.23% to $5.6 million in 2024.
- The last three Gains from Investment Securities figures came in at $5.6 million (Q4 2024), -$9.2 million (Q2 2024), and $3.7 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Inventiva | 8.52 Mn | -260.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.58 Mn |
| Dec 31, 2024 | 5.58 Mn |
| Jun 30, 2024 | -9.16 Mn |
| Jun 30, 2024 | -9.16 Mn |
| Dec 31, 2023 | 3.66 Mn |
| Dec 31, 2023 | 3.66 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Jun 30, 2021 | -1.89 Mn |
| Jun 30, 2021 | -1.89 Mn |
| Mar 31, 2021 | 2.68 Mn |
| Mar 31, 2021 | 2.68 Mn |